Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Recent filings | ||||||
Filed 2024-03-28 08:46 Tx date 2024-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-627,818.6196
-126,281 vol $4.97 each |
0 | |
Filed 2024-03-28 08:45 Tx date 2024-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$627,818
+126,281 vol $4.97 each |
126,281 | |
Filed 2024-03-28 08:44 Tx date 2024-03-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-872,665.8048
-175,104 vol $4.98 each |
0 | |
Filed 2024-03-28 08:43 Tx date 2024-03-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$872,665
+175,104 vol $4.98 each |
175,104 | |
Filed 2024-03-28 08:42 Tx date 2024-03-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-389,583.1116
-78,126 vol $4.99 each |
0 | |
Filed 2024-03-28 08:41 Tx date 2024-03-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$389,583
+78,126 vol $4.99 each |
78,126 | |
Older filings | ||||||
Filed 2024-03-25 09:18 Tx date 2024-03-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-994,884.48
-199,776 vol $4.98 each |
0 | |
Filed 2024-03-25 09:18 Tx date 2024-03-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$994,884
+199,776 vol $4.98 each |
199,776 | |
Filed 2024-03-08 12:07 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,688 vol |
101,115 | |
Filed 2024-03-08 12:06 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+9,136 vol |
85,427 | |
Filed 2024-03-08 12:05 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-200,110.40
-35,734 vol $5.60 each |
92,284 | |
Filed 2024-03-08 12:00 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-116,569.60
-20,816 vol $5.60 each |
128,018 | |
Filed 2024-03-08 11:52 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,459 vol |
55,250 | |
Filed 2024-03-08 11:51 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-357,392
-63,820 vol $5.60 each |
229,517 | |
Filed 2024-03-08 11:25 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,245,826.40
-222,469 vol $5.60 each |
1,210,556 | |
Filed 2024-03-08 11:20 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-497,982.78
-90,378 vol $5.51 each |
432,116 | |
Filed 2024-03-08 11:19 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-191,158.43
-34,693 vol $5.51 each |
522,494 | |
Filed 2024-03-08 11:10 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+144,781 vol |
311,558 | |
Filed 2024-03-08 11:09 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+54,787 vol |
166,777 | |
Filed 2024-03-08 11:07 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-1,245,826.40
-222,469 vol $5.60 each |
||
Filed 2024-03-08 11:05 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-582,848
-104,080 vol $5.60 each |
1,433,025 | |
Filed 2024-03-08 10:54 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+38,952 vol |
73,928 | |
Filed 2024-03-08 10:53 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-317,682.40
-56,729 vol $5.60 each |
400,659 | |
Filed 2024-03-08 10:48 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+61,087 vol |
151,956 | |
Filed 2024-03-08 10:48 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,319 vol |
90,869 | |
Filed 2024-03-08 10:45 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-506,116.80
-90,378 vol $5.60 each |
||
Filed 2024-03-08 10:45 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-506,116.80
-90,378 vol $5.60 each |
432,116 | |
Filed 2024-03-08 10:44 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
||
Filed 2024-03-08 10:44 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
522,494 | |
Filed 2024-03-08 10:39 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,982 vol |
78,360 | |
Filed 2024-03-08 10:38 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,236 vol |
48,378 | |
Filed 2024-03-08 10:37 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-382,312
-68,270 vol $5.60 each |
365,464 | |
Filed 2024-03-08 10:34 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
433,734 | |
Filed 2024-03-08 10:27 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+52,628 vol |
112,133 | |
Filed 2024-03-08 10:26 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,727 vol |
59,505 | |
Filed 2024-03-08 10:23 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-428,248.80
-76,473 vol $5.60 each |
383,795 | |
Filed 2024-03-08 10:21 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
460,268 | |
Filed 2024-02-29 10:46 Tx date 2024-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-30,073
-4,930 vol $6.10 each |
25,791 | |
Filed 2024-02-29 09:59 Tx date 2024-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-57,507.3055
-9,805 vol $5.87 each |
0 | |
Filed 2024-02-29 09:58 Tx date 2024-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$57,507
+9,805 vol $5.87 each |
9,805 | |
Filed 2024-02-29 09:58 Tx date 2024-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-125,067.6325
-20,975 vol $5.96 each |
0 | |
Filed 2024-02-29 09:57 Tx date 2024-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,067
+20,975 vol $5.96 each |
20,975 | |
Filed 2024-02-29 09:57 Tx date 2024-02-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-1,511,269.1848
-252,653 vol $5.98 each |
0 | |
Filed 2024-02-29 09:56 Tx date 2024-02-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,511,269
+252,653 vol $5.98 each |
252,653 | |
Filed 2024-02-26 10:38 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,304,900
+4,930 vol $4,930 each |
67,550 | |
Filed 2024-02-26 10:37 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+216,666 vol |
557,187 | |
Filed 2024-02-26 10:24 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,976 vol |
34,976 | |
Filed 2024-02-26 10:22 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+195,512 vol |
457,388 | |
Filed 2024-02-26 10:21 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-251,219.64
-45,843 vol $5.48 each |
261,876 | |
Filed 2024-02-26 09:52 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+25,791 vol |
30,721 | |
Filed 2024-02-26 09:50 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+4,930 vol |
4,930 | |
Filed 2024-02-26 09:49 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-02-26 09:48 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-279,134.76
-50,937 vol $5.48 each |
293,337 | |
Filed 2024-02-26 09:23 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+661,538 vol |
1,537,105 | |
Filed 2024-02-26 09:21 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+4,886 vol |
111,990 | |
Filed 2024-02-26 09:17 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,033 vol |
104,000 | |
Filed 2024-02-26 09:11 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-913,822.40
-104,080 vol $8.78 each |
875,567 | |
Filed 2023-03-07 10:32 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,330 vol |
||
Filed 2023-03-07 10:31 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-930,475.20
-104,080 vol $8.94 each |
||
Filed 2024-02-23 16:40 Tx date 2024-02-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-1,064,755.9796
-178,372 vol $5.97 each |
0 | |
Filed 2024-02-23 16:40 Tx date 2024-02-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,064,755
+178,372 vol $5.97 each |
178,372 | |
Filed 2024-02-23 16:39 Tx date 2024-02-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-3,418,183.2384
-587,559 vol $5.82 each |
0 | |
Filed 2024-02-23 16:38 Tx date 2024-02-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,418,183
+587,559 vol $5.82 each |
587,559 | |
Filed 2024-02-23 16:37 Tx date 2024-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-3,823,204.9466
-683,423 vol $5.59 each |
0 | |
Filed 2024-02-23 16:36 Tx date 2024-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,823,204
+683,423 vol $5.59 each |
683,423 | |
Filed 2024-02-23 16:33 Tx date 2024-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-02-23 11:25 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+194,230 vol |
468,427 | |
Filed 2024-02-23 11:23 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+4,217 vol |
33,142 | |
Filed 2024-02-23 11:21 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-304,604.54
-34,693 vol $8.78 each |
274,197 | |
Filed 2024-02-23 11:17 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,049 vol |
26,731 | |
Filed 2023-03-07 09:46 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,291 vol |
||
Filed 2023-03-07 09:39 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-310,155.42
-34,693 vol $8.94 each |
||
Filed 2023-09-27 12:52 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
99 - Correction of information
|
-1,250,000 vol |
0 | |
Filed 2023-09-27 12:51 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
-3,750,000 vol |
32,900 | |
Filed 2023-09-27 12:49 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Foster Investments Ltd. (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
-4,328,890 vol |
0 | |
Filed 2023-09-27 12:48 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-2,006,820 vol |
0 | |
Filed 2023-09-25 12:36 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+20,383 vol |
20,383 | |
Filed 2023-09-25 12:33 Tx date 2009-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-09-25 12:30 Tx date 2023-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,386
+32,900 vol $8.34 each |
3,782,900 | |
Filed 2023-08-22 14:13 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+17,913 vol |
17,913 | |
Filed 2023-08-22 14:12 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-22 14:11 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,820
+28,959 vol $9.49 each |
28,959 | |
Filed 2023-08-22 14:08 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-22 14:00 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+17,913 vol |
17,913 | |
Filed 2023-08-22 13:59 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-22 13:57 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,820
+28,959 vol $9.49 each |
28,959 | |
Filed 2023-08-22 13:18 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-24 15:07 Tx date 2023-05-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,461 vol |
11,961 | |
Filed 2023-05-24 15:05 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-24 15:03 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
78,733 | |
Filed 2023-05-24 15:02 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-24 14:59 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
141,193 | |
Filed 2023-05-24 14:57 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-24 14:56 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,918 vol |
9,218 | |
Filed 2023-05-24 14:53 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-24 14:44 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
186,193 | |
Filed 2023-05-24 14:43 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-24 14:41 Tx date 2023-05-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,333.58
-8,733 vol $11.26 each |
40,000 | |
Filed 2023-05-24 14:40 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
48,733 | |
Filed 2023-05-24 14:37 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-24 14:30 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
83,137 | |
Filed 2023-05-24 14:24 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
156,193 | |
Filed 2023-05-24 14:17 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,083 vol |
24,083 | |
Filed 2023-05-24 14:13 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-24 14:02 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-24 14:01 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
||
Filed 2023-05-24 13:53 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-24 13:49 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
8,733 | |
Filed 2023-05-24 13:48 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-24 13:47 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-05-23 19:01 Tx date 2023-05-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-73,233.60
-4,818 vol $15.20 each |
3,915 | |
Filed 2023-05-23 18:58 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$126,628
+8,733 vol $14.50 each |
8,733 | |
Filed 2023-05-23 18:36 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$126,628
+8,733 vol $14.50 each |
||
Filed 2023-05-23 18:23 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,234 vol |
141,193 | |
Filed 2023-05-23 18:21 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-23 18:16 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$126,628
+8,733 vol $14.50 each |
||
Filed 2023-05-23 18:15 Tx date 2019-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-23 18:12 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2023-03-07 10:52 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,816 vol |
76,291 | |
Filed 2023-03-07 10:50 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-20,816 vol |
148,834 | |
Filed 2023-03-07 10:49 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+107,202 vol |
169,650 | |
Filed 2023-03-07 10:44 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$178,283
+20,000 vol $8.91 each |
70,000 | |
Filed 2023-03-07 10:40 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,693 vol |
62,620 | |
Filed 2023-03-07 10:38 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-34,693 vol |
340,521 | |
Filed 2023-03-07 10:37 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+271,134 vol |
375,214 | |
Filed 2023-03-07 10:34 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+3,104 vol |
107,401 | |
Filed 2023-03-07 10:32 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+71,330 vol |
104,297 | |
Filed 2023-03-07 10:31 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-930,475.20
-104,080 vol $8.94 each |
875,567 | |
Filed 2023-03-07 10:27 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+667,407 vol |
979,647 | |
Filed 2023-03-07 10:21 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,399 vol |
32,406 | |
Filed 2023-03-07 10:20 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,397 vol |
30,007 | |
Filed 2023-03-07 10:17 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-310,155.42
-34,693 vol $8.94 each |
298,808 | |
Filed 2023-03-07 10:12 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+229,421 vol |
333,501 | |
Filed 2023-03-07 09:48 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,194 vol |
29,167 | |
Filed 2023-03-07 09:46 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,291 vol |
26,973 | |
Filed 2023-03-07 09:39 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-310,155.42
-34,693 vol $8.94 each |
274,197 | |
Filed 2023-03-07 09:20 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+204,810 vol |
308,890 | |
Filed 2023-03-07 09:14 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+170,188 vol |
307,719 | |
Filed 2023-03-07 09:08 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+191,462 vol |
344,274 | |
Filed 2022-11-23 16:05 Tx date 2022-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,703 vol |
27,927 | |
Filed 2022-11-23 16:04 Tx date 2022-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,600
+10,000 vol $4.66 each |
26,224 | |
Filed 2022-11-15 08:48 Tx date 2022-11-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,075
+5,000 vol $5.01 each |
5,000 | |
Filed 2022-11-15 08:43 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-09 16:14 Tx date 2022-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$154,800
+30,000 vol $5.16 each |
55,475 | |
Filed 2022-08-02 10:00 Tx date 2022-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+152,812 vol |
152,812 | |
Filed 2022-08-02 09:58 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-02 09:58 Tx date 2022-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,101,376
+256,892 vol $8.18 each |
256,892 | |
Filed 2022-08-02 09:51 Tx date 2022-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+137,531 vol |
137,531 | |
Filed 2022-08-02 09:49 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-02 09:47 Tx date 2022-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,891,240
+231,203 vol $8.18 each |
231,203 | |
Filed 2022-07-25 10:44 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-25 10:39 Tx date 2022-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-11 13:17 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,200
+10,000 vol $3.62 each |
40,000 | |
Filed 2022-07-11 13:12 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-47,300
-10,000 vol $4.73 each |
170,959 | |
Filed 2022-05-23 11:35 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
125,959 | |
Filed 2022-05-23 11:34 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:33 Tx date 2020-04-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 11:30 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
210,959 | |
Filed 2022-05-23 11:29 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:28 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 11:26 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
125,959 | |
Filed 2022-05-23 11:24 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:23 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 11:20 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
180,959 | |
Filed 2022-05-23 11:18 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:17 Tx date 2015-05-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 11:14 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
130,959 | |
Filed 2022-05-23 11:07 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:06 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 11:02 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
140,959 | |
Filed 2022-05-23 10:59 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 10:58 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-23 10:46 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
67,903 | |
Filed 2022-05-23 10:40 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 10:38 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-20 21:25 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+14,612 vol |
125,959 | |
Filed 2022-05-20 21:21 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-20 21:19 Tx date 2019-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-11 19:31 Tx date 2022-03-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,985
+5,000 vol $11.00 each |
9,400 | |
Filed 2022-03-11 12:05 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,138,536
+178,063 vol $12.01 each |
621,471 | |
Filed 2022-03-07 11:21 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,078,486
+173,063 vol $12.01 each |
||
Filed 2022-03-08 16:42 Tx date 2022-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,100
+5,000 vol $10.82 each |
50,000 | |
Filed 2022-03-07 22:11 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 22:04 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 17:47 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,654 vol |
90,953 | |
Filed 2022-03-07 17:46 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 17:44 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 17:42 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,500 vol |
11,682 | |
Filed 2022-03-07 17:41 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
-8,500 vol |
0 | |
Filed 2022-03-07 17:40 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 17:38 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,440 vol |
6,610 | |
Filed 2022-03-07 17:37 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 17:27 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 17:22 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,651 vol |
25,475 | |
Filed 2022-03-07 17:20 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
||
Filed 2022-03-07 17:20 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 17:18 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 17:15 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,651 vol |
69,379 | |
Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
||
Filed 2022-03-07 17:11 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 17:08 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,232 vol |
32,967 | |
Filed 2022-03-07 17:07 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-339,883
-28,300 vol $12.01 each |
0 | |
Filed 2022-03-07 17:05 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-113,200 vol |
28,300 | |
Filed 2022-03-07 16:57 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,448 vol |
16,224 | |
Filed 2022-03-07 16:51 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 16:47 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 16:34 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$63,592
+5,295 vol $12.01 each |
13,495 | |
Filed 2022-03-07 16:30 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
Filed 2022-03-07 15:50 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+8,500 vol |
||
Filed 2022-03-07 15:50 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+8,500 vol |
16,700 | |
Filed 2022-03-07 15:47 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
50 - Grant of options
|
-8,500 vol |
0 | |
Filed 2022-03-07 15:47 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
50 - Grant of options
|
-8,500 vol |
||
Filed 2022-03-07 15:44 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
Filed 2022-03-07 15:37 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+312,240 vol |
312,240 | |
Filed 2022-03-07 15:36 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:34 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+72,856 vol |
72,856 | |
Filed 2022-03-07 15:33 Tx date 2013-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:31 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+104,080 vol |
104,080 | |
Filed 2022-03-07 15:21 Tx date 2014-06-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:18 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+104,080 vol |
104,080 | |
Filed 2022-03-07 15:16 Tx date 2020-04-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:13 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+62,448 vol |
62,448 | |
Filed 2022-03-07 15:12 Tx date 2013-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:09 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+62,448 vol |
62,448 | |
Filed 2022-03-07 15:07 Tx date 2011-08-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 15:04 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+104,080 vol |
104,080 | |
Filed 2022-03-07 15:00 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 14:58 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+104,080 vol |
104,080 | |
Filed 2022-03-07 14:37 Tx date 2020-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-07 13:01 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+462 vol |
3,182 | |
Filed 2022-03-07 12:56 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+170 vol |
1,170 | |
Filed 2022-03-07 12:49 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+282 vol |
13,735 | |
Filed 2022-03-07 12:42 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+876 vol |
10,776 | |
Filed 2022-03-07 11:32 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,415,597
+534,188 vol $12.01 each |
3,363,988 | |
Filed 2022-03-07 11:27 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,496,974
+124,644 vol $12.01 each |
420,734 | |
Filed 2022-03-07 11:21 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,078,486
+173,063 vol $12.01 each |
616,471 | |
Filed 2022-03-07 11:13 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,138,536
+178,063 vol $12.01 each |
631,113 | |
Filed 2022-03-07 11:07 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,283,124
+106,838 vol $12.01 each |
217,363 | |
Filed 2022-03-07 11:02 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,283,124
+106,838 vol $12.01 each |
560,395 | |
Filed 2022-03-07 10:55 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,138,536
+178,063 vol $12.01 each |
791,515 | |
Filed 2022-03-07 10:05 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,138,536
+178,063 vol $12.01 each |
850,700 | |
Filed 2022-01-04 17:32 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,765.86
-634 vol $23.29 each |
3,500 | |
Filed 2022-01-04 17:32 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-888,884.28
-39,366 vol $22.58 each |
4,134 | |
Filed 2022-01-04 17:29 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$203,200
+40,000 vol $5.08 each |
43,500 | |
Filed 2022-01-04 17:27 Tx date 2022-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-256,000
-40,000 vol $6.40 each |
116,347 | |
Filed 2021-12-16 10:02 Tx date 2021-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,064
+1,600 vol $20.04 each |
5,300 | |
Filed 2021-11-12 16:37 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-324,500
-11,000 vol $29.50 each |
21,824 | |
Filed 2021-11-12 16:36 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-835,780
-29,000 vol $28.82 each |
32,824 | |
Filed 2021-11-12 16:35 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$835,780
+29,000 vol $28.82 each |
61,824 | |
Filed 2021-11-12 16:33 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-702,380
-29,000 vol $24.22 each |
110,525 | |
Filed 2021-11-12 16:31 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-305,500
-10,000 vol $30.55 each |
32,824 | |
Filed 2021-11-12 16:30 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,527,500
-50,000 vol $30.55 each |
42,824 | |
Filed 2021-11-12 16:29 Tx date 2021-11-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,508,500
-50,000 vol $30.17 each |
92,824 | |
Filed 2021-11-12 16:02 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,889,000
-100,000 vol $28.89 each |
87,299 | |
Filed 2021-11-12 16:01 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$530,000
+100,000 vol $5.30 each |
187,299 | |
Filed 2021-11-12 16:00 Tx date 2021-11-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-652,000
-100,000 vol $6.52 each |
296,090 | |
Filed 2021-11-12 15:58 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-305,500
-10,000 vol $30.55 each |
87,299 | |
Filed 2021-11-12 15:57 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,805,300
-90,000 vol $31.17 each |
97,299 | |
Filed 2021-11-12 15:57 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,000
+30,000 vol $5.30 each |
187,299 | |
Filed 2021-11-12 15:56 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-195,600
-30,000 vol $6.52 each |
396,090 | |
Filed 2021-11-12 15:53 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$424,200
+70,000 vol $6.06 each |
157,299 | |
Filed 2021-11-12 15:49 Tx date 2021-11-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-562,800
-70,000 vol $8.04 each |
426,090 | |
Filed 2021-11-12 15:41 Tx date 2021-11-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,508,500
-50,000 vol $30.17 each |
87,299 | |
Filed 2021-11-04 09:54 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,423,800
-45,000 vol $31.64 each |
142,824 | |
Filed 2021-11-04 09:53 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+45,000 vol $3.20 each |
187,824 | |
Filed 2021-11-04 09:45 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-189,450
-45,000 vol $4.21 each |
139,525 | |
Filed 2021-11-04 09:38 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,423,800
-45,000 vol $31.64 each |
137,299 | |
Filed 2021-11-04 09:36 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238,500
+45,000 vol $5.30 each |
182,299 | |
Filed 2021-11-04 09:34 Tx date 2021-11-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-293,400
-45,000 vol $6.52 each |
496,090 | |
Filed 2021-10-27 09:41 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,867,500
-130,000 vol $29.75 each |
65,728 | |
Filed 2021-10-27 09:40 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$304,000
+95,000 vol $3.20 each |
195,728 | |
Filed 2021-10-27 09:38 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-399,950
-95,000 vol $4.21 each |
453,557 | |
Filed 2021-09-23 15:12 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,101,750
-87,500 vol $24.02 each |
142,824 | |
Filed 2021-09-23 15:10 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$183,800
+10,000 vol $18.38 each |
230,324 | |
Filed 2021-09-23 15:09 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$424,200
+70,000 vol $6.06 each |
220,324 | |
Filed 2021-09-23 15:09 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,750
+7,500 vol $5.30 each |
150,324 | |
Filed 2021-09-23 15:08 Tx date 2021-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-345,600
-16,000 vol $21.60 each |
142,824 | |
Filed 2021-09-23 15:07 Tx date 2021-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-271,375
-12,500 vol $21.71 each |
158,824 | |
Filed 2021-09-23 15:05 Tx date 2021-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$151,050
+28,500 vol $5.30 each |
171,324 | |
Filed 2021-09-23 15:03 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-242,200
-10,000 vol $24.22 each |
184,525 | |
Filed 2021-09-23 15:01 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-562,800
-70,000 vol $8.04 each |
194,525 | |
Filed 2021-09-23 14:58 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-48,900
-7,500 vol $6.52 each |
264,525 | |
Filed 2021-09-23 14:56 Tx date 2021-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-185,820
-28,500 vol $6.52 each |
272,025 | |
Filed 2021-09-23 14:43 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-126,912.24
-5,364 vol $23.66 each |
100,728 | |
Filed 2021-09-23 14:42 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-652,620.80
-27,136 vol $24.05 each |
106,092 | |
Filed 2021-09-23 14:41 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,635
+11,136 vol $3.20 each |
133,228 | |
Filed 2021-09-23 14:40 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,080
+16,000 vol $2.63 each |
122,092 | |
Filed 2021-09-23 14:38 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-46,882.56
-11,136 vol $4.21 each |
548,557 | |
Filed 2021-09-23 14:35 Tx date 2021-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-56,000
-16,000 vol $3.50 each |
559,693 | |
Filed 2021-09-17 15:48 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-159,300
-30,000 vol $5.31 each |
142,824 | |
Filed 2021-09-17 15:47 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-304,220
-14,000 vol $21.73 each |
172,824 | |
Filed 2021-09-17 15:45 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$233,639
+44,000 vol $5.31 each |
186,824 | |
Filed 2021-09-17 15:44 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-286,880
-44,000 vol $6.52 each |
300,525 | |
Filed 2021-09-17 15:39 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-144,000
-45,000 vol $3.20 each |
142,824 | |
Filed 2021-09-17 15:38 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+45,000 vol $3.20 each |
187,824 | |
Filed 2021-09-17 15:37 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-189,450
-45,000 vol $4.21 each |
344,525 | |
Filed 2021-09-17 15:34 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-238,950
-45,000 vol $5.31 each |
142,824 | |
Filed 2021-09-17 15:33 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238,949
+45,000 vol $5.31 each |
187,824 | |
Filed 2021-09-17 15:30 Tx date 2021-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-293,400
-45,000 vol $6.52 each |
389,525 | |
Filed 2021-09-17 15:24 Tx date 2021-09-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-132,750
-25,000 vol $5.31 each |
142,824 | |
Filed 2021-09-17 15:22 Tx date 2021-09-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,750
+25,000 vol $5.31 each |
167,824 | |
Filed 2021-09-17 15:18 Tx date 2021-09-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-163,000
-25,000 vol $6.52 each |
434,525 | |
Filed 2021-09-16 11:51 Tx date 2021-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,976,000
-150,000 vol $19.84 each |
137,299 | |
Filed 2021-09-16 11:49 Tx date 2021-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480,000
+150,000 vol $3.20 each |
287,299 | |
Filed 2021-09-16 11:45 Tx date 2021-09-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-631,500
-150,000 vol $4.21 each |
541,090 | |
Filed 2021-09-15 16:06 Tx date 2021-09-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-687,375
-32,500 vol $21.15 each |
106,092 | |
Filed 2021-09-08 15:47 Tx date 2021-09-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,500
-5,000 vol $18.30 each |
138,592 | |
Filed 2021-09-08 15:37 Tx date 2021-09-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-135,750
-7,500 vol $18.10 each |
142,824 | |
Filed 2021-08-27 16:21 Tx date 2021-08-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-400,725
-22,500 vol $17.81 each |
150,324 | |
Filed 2021-08-26 16:26 Tx date 2021-08-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-79,250
-5,000 vol $15.85 each |
137,299 | |
Filed 2021-08-10 16:17 Tx date 2021-08-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,050
-5,000 vol $16.01 each |
172,824 | |
Filed 2021-08-10 16:05 Tx date 2021-08-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-721,350
-45,000 vol $16.03 each |
142,299 | |
Filed 2021-07-29 16:27 Tx date 2021-07-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,073
-5,000 vol $17.41 each |
177,824 | |
Filed 2021-06-23 16:37 Tx date 2021-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-85,050
-5,000 vol $17.01 each |
182,824 | |
Filed 2021-06-18 11:17 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+31,347 vol |
111,347 | |
Filed 2021-06-17 17:13 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
111,347 | |
Filed 2021-06-17 17:09 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
111,347 | |
Filed 2021-06-17 17:06 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
166,347 | |
Filed 2021-06-17 17:03 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
156,347 | |
Filed 2021-06-17 16:59 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
126,347 | |
Filed 2021-06-17 16:56 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$685,322
+53,291 vol $12.86 each |
53,291 | |
Filed 2021-06-17 16:54 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-17 16:50 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
196,347 | |
Filed 2021-05-12 18:48 Tx date 2021-05-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: TFSA (RHM) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,040
+1,600 vol $11.28 each |
1,600 | |
Filed 2021-05-12 18:48 Tx date 2019-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: TFSA (RHM) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-12 18:45 Tx date 2021-05-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,764
+1,400 vol $11.26 each |
4,400 | |
Filed 2021-05-12 18:45 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,140
+1,000 vol $11.14 each |
3,000 | |
Filed 2021-05-12 18:44 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,585
+500 vol $11.17 each |
2,000 | |
Filed 2021-05-12 17:26 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,693
+9,900 vol $10.07 each |
9,900 | |
Filed 2021-05-12 17:25 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-12 17:23 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,888
+5,125 vol $10.71 each |
13,453 | |
Filed 2021-05-12 17:18 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$78,200
+20,000 vol $3.91 each |
187,824 | |
Filed 2021-05-12 17:18 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-78,200
-20,000 vol $3.91 each |
459,525 | |
Filed 2021-05-12 16:28 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,389
+2,500 vol $10.96 each |
3,700 | |
Filed 2021-05-11 17:27 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$156,400
+40,000 vol $3.91 each |
143,592 | |
Filed 2021-05-11 17:26 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-156,400
-40,000 vol $3.91 each |
575,693 | |
Filed 2021-05-11 16:55 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,740
+1,000 vol $9.74 each |
1,000 | |
Filed 2021-03-15 21:52 Tx date 2021-03-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-40,000 vol |
187,299 | |
Filed 2021-03-15 21:52 Tx date 2021-03-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$156,400
+40,000 vol $3.91 each |
227,299 | |
Filed 2021-03-15 21:51 Tx date 2021-03-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-156,400
-40,000 vol $3.91 each |
691,090 | |
Filed 2021-03-09 13:28 Tx date 2021-03-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,000
+5,000 vol $13.00 each |
45,000 | |
Filed 2021-02-01 19:00 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, ALISON (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,172
+150 vol $21.15 each |
150 | |
Filed 2021-02-01 18:59 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, ALISON (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 18:59 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, LINSEY (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,172
+150 vol $21.15 each |
150 | |
Filed 2021-02-01 18:58 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, LINSEY (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 18:58 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, MITCHELL R. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,115
+100 vol $21.15 each |
100 | |
Filed 2021-02-01 18:57 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, MITCHELL R. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 18:57 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, DAVID (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,460
+400 vol $21.15 each |
400 | |
Filed 2021-02-01 18:56 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, DAVID (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 18:56 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,380
+1,200 vol $21.15 each |
1,200 | |
Filed 2021-02-01 15:21 Tx date 2020-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: Shelburne Wood Protection (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,240
+1,000 vol $21.24 each |
1,000 | |
Filed 2021-02-01 15:21 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Holder: Shelburne Wood Protection (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 15:12 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
Filed 2021-02-01 15:12 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
Filed 2021-02-01 15:11 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$346,000
+50,000 vol $6.92 each |
50,000 | |
Filed 2021-02-01 15:10 Tx date 2018-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-01 15:10 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-125,850
-15,000 vol $8.39 each |
30,000 | |
Filed 2021-02-01 15:09 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-241,200
-30,000 vol $8.04 each |
45,000 | |
Filed 2021-02-01 15:08 Tx date 2021-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-346,000
-50,000 vol $6.92 each |
75,000 | |
Filed 2020-06-04 14:24 Tx date 2020-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,240
+1,000 vol $21.24 each |
||
Filed 2021-01-29 12:51 Tx date 2021-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,526
+900 vol $16.14 each |
2,720 | |
Filed 2020-12-31 14:37 Tx date 2019-01-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-82,450
-19,400 vol $4.25 each |
368,039 | |
Filed 2020-12-31 14:36 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-170,000
-40,000 vol $4.25 each |
387,439 | |
Filed 2020-12-31 14:27 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-92,909.25
-21,861 vol $4.25 each |
330,000 | |
Filed 2020-12-31 14:26 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-78,200
-20,000 vol $3.91 each |
351,861 | |
Filed 2020-12-31 14:25 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-145,000
-20,000 vol $7.25 each |
||
Filed 2020-12-31 14:25 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-117,180
-21,000 vol $5.58 each |
||
Filed 2020-12-31 14:24 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-89,250
-21,000 vol $4.25 each |
371,861 | |
Filed 2020-12-31 14:22 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-192,006.50
-45,178 vol $4.25 each |
392,861 | |
Filed 2020-12-31 10:32 Tx date 2020-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2020-12-31 10:32 Tx date 2020-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,600
-10,000 vol $3.96 each |
135,000 | |
Filed 2019-12-17 10:19 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$92,909
+21,861 vol $4.25 each |
||
Filed 2019-10-01 14:07 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-145,000
-20,000 vol $7.25 each |
||
Filed 2019-10-01 14:02 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-117,180
-21,000 vol $5.58 each |
||
Filed 2019-10-01 14:00 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$78,200
+20,000 vol $3.91 each |
||
Filed 2019-10-01 13:58 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$89,250
+21,000 vol $4.25 each |
||
Filed 2019-05-02 15:50 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$192,006
+45,178 vol $4.25 each |
||
Filed 2020-12-30 16:54 Tx date 2020-12-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,624
+2,200 vol $13.92 each |
8,200 | |
Filed 2020-12-30 16:53 Tx date 2020-12-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,580
+2,000 vol $14.29 each |
6,000 | |
Filed 2020-12-30 16:53 Tx date 2020-12-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,816
+800 vol $13.52 each |
4,000 | |
Filed 2020-12-30 16:52 Tx date 2020-12-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,232
+3,200 vol $13.51 each |
3,200 | |
Filed 2020-12-28 14:28 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,076,603
+82,625 vol $13.03 each |
714,003 | |
Filed 2020-12-28 14:19 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-12-28 14:18 Tx date 2013-09-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-23 19:00 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,882,626
+144,484 vol $13.03 each |
443,408 | |
Filed 2020-12-23 18:55 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,921,117
+224,184 vol $13.03 each |
731,090 | |
Filed 2020-12-23 18:53 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,219,516
+93,593 vol $13.03 each |
615,693 | |
Filed 2020-12-23 18:52 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-140,304.05
-31,529 vol $4.45 each |
522,100 | |
Filed 2020-12-23 18:34 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,087,484
+236,952 vol $13.03 each |
613,452 | |
Filed 2020-12-23 18:32 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,385,637
+336,580 vol $13.03 each |
672,637 | |
Filed 2020-12-23 18:30 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,645,822
+817,024 vol $13.03 each |
2,829,800 | |
Filed 2020-12-23 18:28 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,526,048
+270,610 vol $13.03 each |
453,050 | |
Filed 2020-08-20 16:06 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
||
Filed 2020-12-21 18:59 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$262,076
+20,000 vol $13.10 each |
40,000 | |
Filed 2020-11-17 14:31 Tx date 2020-11-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,005,581
+298,924 vol $13.40 each |
298,924 | |
Filed 2020-11-17 14:27 Tx date 2014-06-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-28 11:03 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-28 11:03 Tx date 2013-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 17:20 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-26 17:19 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 17:19 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,063,830
+126,500 vol $24.22 each |
376,500 | |
Filed 2020-10-26 17:17 Tx date 2019-08-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,962,500
+250,000 vol $7.85 each |
250,000 | |
Filed 2020-10-26 17:16 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 15:13 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+141,500 vol |
141,500 | |
Filed 2020-10-26 15:12 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 15:07 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-26 15:07 Tx date 2020-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 14:58 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-26 14:58 Tx date 2011-08-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 14:55 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-26 14:54 Tx date 2014-06-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-26 14:14 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
Filed 2020-10-26 14:11 Tx date 2020-04-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-25 18:13 Tx date 2020-09-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-731,051.9254
-48,458 vol $15.09 each |
6,499,881 | |
Filed 2020-09-25 18:12 Tx date 2020-09-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-731,051.9254
-48,458 vol $15.09 each |
||
Filed 2020-09-25 18:09 Tx date 2020-09-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-731,051.9254
-48,458 vol $15.09 each |
||
Filed 2020-09-18 18:19 Tx date 2020-09-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-727,265.3232
-48,464 vol $15.01 each |
6,548,339 | |
Filed 2020-09-18 18:18 Tx date 2020-09-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,121,956.7516
-140,553 vol $15.10 each |
6,596,803 | |
Filed 2020-09-18 18:16 Tx date 2020-09-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-320,281.4264
-21,316 vol $15.03 each |
6,737,356 | |
Filed 2020-08-20 16:10 Tx date 2020-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-266,176.40
-14,000 vol $19.01 each |
103,592 | |
Filed 2020-08-20 16:08 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
117,592 | |
Filed 2020-08-20 16:06 Tx date 2020-08-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$140,304
+31,529 vol $4.45 each |
585,158 | |
Filed 2020-07-24 11:25 Tx date 2020-07-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,844,800
-600,000 vol $16.41 each |
6,758,672 | |
Filed 2020-07-11 19:07 Tx date 2020-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-211,500
-10,000 vol $21.15 each |
187,299 | |
Filed 2020-06-26 18:00 Tx date 2020-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,307,581.395
-79,825 vol $16.38 each |
7,358,672 | |
Filed 2020-06-16 12:00 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
80,000 | |
Filed 2020-06-16 11:57 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
145,000 | |
Filed 2020-06-16 11:55 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
125,000 | |
Filed 2020-06-16 11:53 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
165,000 | |
Filed 2020-06-16 11:50 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
125,000 | |
Filed 2020-06-16 11:47 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
95,000 | |
Filed 2020-06-16 11:41 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
80,000 | |
Filed 2020-06-16 11:24 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
80,000 | |
Filed 2020-06-03 20:26 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 20:25 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
Filed 2020-06-03 20:24 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 20:22 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 14:40 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 14:35 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 14:31 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 14:27 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-04 14:24 Tx date 2020-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,240
+1,000 vol $21.24 each |
1,000 | |
Filed 2020-06-03 20:26 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
80,000 | |
Filed 2020-06-03 20:25 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
80,000 | |
Filed 2020-06-03 20:24 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
125,000 | |
Filed 2020-06-03 20:22 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
125,000 | |
Filed 2020-06-03 14:40 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
95,000 | |
Filed 2020-06-03 14:35 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
80,000 | |
Filed 2020-06-03 14:31 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
165,000 | |
Filed 2020-06-03 14:27 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
145,000 | |
Filed 2020-05-25 16:02 Tx date 2020-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$69,822
+16,200 vol $4.31 each |
20,000 | |
Filed 2020-05-25 15:59 Tx date 2020-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-69,822
-16,200 vol $4.31 each |
115,000 | |
Filed 2020-05-25 15:48 Tx date 2020-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,189,000
+50,000 vol $23.78 each |
182,440 | |
Filed 2020-05-20 10:57 Tx date 2020-05-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-331,934.5191
-18,399 vol $18.04 each |
3,354,918 | |
Filed 2020-05-20 10:55 Tx date 2020-05-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-697,963.14
-37,575 vol $18.58 each |
3,373,317 | |
Filed 2020-05-15 18:20 Tx date 2020-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,627,600
-200,000 vol $18.14 each |
7,438,497 | |
Filed 2020-05-11 15:39 Tx date 2020-05-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,707,010
-100,000 vol $17.07 each |
7,638,497 | |
Filed 2020-05-11 15:38 Tx date 2020-05-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,883,659.2057
-110,151 vol $17.10 each |
7,738,497 | |
Filed 2020-05-11 15:36 Tx date 2020-05-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,814,138.1478
-162,302 vol $17.34 each |
7,848,648 | |
Filed 2020-05-11 15:32 Tx date 2019-12-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+430,000 vol |
3,410,892 | |
Filed 2020-05-11 15:29 Tx date 2019-12-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,980,892 vol |
2,980,892 | |
Filed 2020-05-11 15:24 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-01 19:18 Tx date 2020-04-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,032,876
+132,440 vol $22.90 each |
132,440 | |
Filed 2020-05-01 19:12 Tx date 2020-04-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-01 19:10 Tx date 2020-04-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-04-21 17:37 Tx date 2020-04-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,070,500
+50,000 vol $21.41 each |
50,000 | |
Filed 2020-04-21 17:32 Tx date 2020-04-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-04-21 17:30 Tx date 2020-04-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-04-11 12:46 Tx date 2020-04-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,279.17
-4,100 vol $21.04 each |
197,299 | |
Filed 2020-04-10 01:44 Tx date 2020-04-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,413
-900 vol $21.57 each |
201,399 | |
Filed 2020-04-10 01:42 Tx date 2020-04-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-316,617
-15,000 vol $21.11 each |
202,299 | |
Filed 2020-03-17 17:46 Tx date 2020-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-03-17 17:45 Tx date 2020-03-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,761,466
+336,057 vol $20.12 each |
336,057 | |
Filed 2020-03-17 17:43 Tx date 2020-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-03-14 19:08 Tx date 2020-03-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,275,307
-60,700 vol $21.01 each |
217,299 | |
Filed 2020-02-15 09:25 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$947,002
+39,100 vol $24.22 each |
260,906 | |
Filed 2020-02-06 19:10 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,692,978
+69,900 vol $24.22 each |
506,906 | |
Filed 2020-02-06 17:33 Tx date 2020-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,645,493
+412,776 vol $25.79 each |
2,012,776 | |
Filed 2020-02-05 14:53 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,620,318
+66,900 vol $24.22 each |
631,378 | |
Filed 2020-02-05 13:39 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,181,936
+48,800 vol $24.22 each |
566,300 | |
Filed 2020-02-05 13:21 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,479,842
+61,100 vol $24.22 each |
553,629 | |
Filed 2020-02-04 18:09 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,688,134
+69,700 vol $24.22 each |
598,037 | |
Filed 2020-01-31 20:33 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,170,352.88
-63,194 vol $18.52 each |
4,000 | |
Filed 2020-01-31 20:31 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$266,046
+63,194 vol $4.21 each |
67,194 | |
Filed 2020-01-31 20:29 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-266,046.74
-63,194 vol $4.21 each |
221,806 | |
Filed 2020-01-22 15:05 Tx date 2020-01-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,408
+500 vol $18.82 each |
1,500 | |
Filed 2020-01-06 08:21 Tx date 2020-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,050,500
-50,000 vol $21.01 each |
4,000 | |
Filed 2020-01-06 08:21 Tx date 2020-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$183,000
+50,000 vol $3.66 each |
54,000 | |
Filed 2020-01-06 08:18 Tx date 2020-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-183,000
-50,000 vol $3.66 each |
285,000 | |
Filed 2020-01-05 20:37 Tx date 2020-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-82,860
-3,000 vol $27.62 each |
70,891 | |
Filed 2019-12-20 19:11 Tx date 2019-12-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,298
+500 vol $18.60 each |
1,000 | |
Filed 2019-12-20 19:10 Tx date 2019-12-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,353
+500 vol $18.71 each |
500 | |
Filed 2019-12-20 19:10 Tx date 2019-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-12-20 18:38 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,325,800
-70,000 vol $18.94 each |
86,063 | |
Filed 2019-12-20 18:36 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$425,034
+100,008 vol $4.25 each |
156,063 | |
Filed 2019-12-20 18:35 Tx date 2019-12-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,008 vol |
492,529 | |
Filed 2019-12-17 17:54 Tx date 2019-12-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-120,400
-5,000 vol $24.08 each |
73,891 | |
Filed 2019-12-17 17:53 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,362,000
-75,000 vol $18.16 each |
78,891 | |
Filed 2019-12-17 17:52 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-122,750
-5,000 vol $24.55 each |
16,452 | |
Filed 2019-12-17 17:49 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$584,115
+137,439 vol $4.25 each |
153,891 | |
Filed 2019-12-17 17:46 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-137,439 vol |
528,337 | |
Filed 2019-12-17 10:24 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+20,000 vol |
167,824 | |
Filed 2019-12-17 10:23 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+20,000 vol |
||
Filed 2019-12-17 10:21 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+20,000 vol |
||
Filed 2019-12-17 10:19 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$92,909
+21,861 vol $4.25 each |
564,478 | |
Filed 2019-12-16 21:47 Tx date 2019-12-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,625,680
-200,000 vol $18.13 each |
8,010,950 | |
Filed 2019-12-16 18:18 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-483,040
-20,000 vol $24.15 each |
277,999 | |
Filed 2019-12-16 14:41 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,253,340.27
-68,601 vol $18.27 each |
4,000 | |
Filed 2019-12-16 14:40 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$251,079
+68,601 vol $3.66 each |
72,601 | |
Filed 2019-12-16 14:39 Tx date 2019-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-251,079.66
-68,601 vol $3.66 each |
335,000 | |
Filed 2019-12-16 14:13 Tx date 2019-12-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-202,290
-11,000 vol $18.39 each |
4,000 | |
Filed 2019-12-11 11:05 Tx date 2019-09-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Total Return Swap
70 - Acquisition or disposition (writing) of third party derivative
|
+1 vol |
1 | |
Filed 2019-12-11 11:02 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Total Return Swap
00 - Opening Balance-Initial SEDI Report
|
1 | ||
Filed 2019-12-09 17:10 Tx date 2019-12-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,436,240
-800,000 vol $15.55 each |
8,210,950 | |
Filed 2019-12-09 17:08 Tx date 2019-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,874,000
-1,100,000 vol $15.34 each |
9,010,950 | |
Filed 2019-12-09 17:06 Tx date 2019-12-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,065,831.58
-541,567 vol $16.74 each |
10,110,950 | |
Filed 2019-12-09 17:05 Tx date 2019-11-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-358,000
-50,000 vol $7.16 each |
10,652,517 | |
Filed 2019-12-09 15:35 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
|
Total Return Swap
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-26 19:46 Tx date 2019-11-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,377,360
-200,000 vol $6.89 each |
10,702,517 | |
Filed 2019-11-26 19:44 Tx date 2019-11-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-612,740
-100,000 vol $6.13 each |
10,902,517 | |
Filed 2019-11-26 19:38 Tx date 2019-11-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,519.60
-3,892 vol $6.30 each |
11,002,517 | |
Filed 2019-11-26 19:36 Tx date 2019-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-615,210
-100,000 vol $6.15 each |
11,006,409 | |
Filed 2019-11-21 18:26 Tx date 2019-11-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$379,500
+50,000 vol $7.59 each |
50,000 | |
Filed 2019-11-21 18:19 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-21 18:17 Tx date 2019-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-21 13:27 Tx date 2019-10-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,600
+10,000 vol $4.96 each |
20,000 | |
Filed 2019-10-17 12:18 Tx date 2019-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-196,200 vol |
147,824 | |
Filed 2019-10-15 16:34 Tx date 2019-10-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,308
+8,328 vol $4.60 each |
8,328 | |
Filed 2019-10-15 16:30 Tx date 2019-10-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,510
+2,000 vol $4.75 each |
3,500 | |
Filed 2019-10-15 16:29 Tx date 2019-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,803
+1,500 vol $3.87 each |
1,500 | |
Filed 2019-10-15 16:28 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-14 17:11 Tx date 2019-10-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,350
+5,000 vol $3.87 each |
15,000 | |
Filed 2019-10-10 23:42 Tx date 2019-10-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,204
+3,800 vol $5.58 each |
344,024 | |
Filed 2019-10-10 13:46 Tx date 2019-10-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,506
+2,000 vol $4.25 each |
2,000 | |
Filed 2019-10-02 11:48 Tx date 2019-09-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,169
+3,000 vol $5.39 each |
10,000 | |
Filed 2019-10-01 14:07 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-145,000
-20,000 vol $7.25 each |
542,617 | |
Filed 2019-10-01 14:02 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-117,180
-21,000 vol $5.58 each |
542,617 | |
Filed 2019-10-01 14:00 Tx date 2019-09-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$78,200
+20,000 vol $3.91 each |
562,617 | |
Filed 2019-10-01 13:58 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$89,250
+21,000 vol $4.25 each |
563,617 | |
Filed 2019-09-26 10:58 Tx date 2019-09-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,812
+1,050 vol $7.44 each |
1,820 | |
Filed 2019-07-09 18:43 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,377
+3,800 vol $4.31 each |
3,800 | |
Filed 2019-07-09 18:42 Tx date 2015-05-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-09 18:41 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,800 vol |
131,200 | |
Filed 2019-07-08 19:12 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,201
+10,000 vol $6.32 each |
10,000 | |
Filed 2019-07-08 19:10 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-05 15:18 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2019-07-05 13:12 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
135,000 | |
Filed 2019-07-05 13:02 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
65,000 | |
Filed 2019-07-05 12:46 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
Filed 2019-07-05 12:37 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
135,000 | |
Filed 2019-07-05 12:33 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
135,000 | |
Filed 2019-07-05 12:26 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
95,000 | |
Filed 2019-07-03 19:20 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
||
Filed 2019-07-03 19:20 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
Filed 2019-07-03 19:14 Tx date 2019-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-03 12:56 Tx date 2019-07-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,772.97
-1,483 vol $6.59 each |
0 | |
Filed 2019-07-01 17:56 Tx date 2019-07-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,200
+2,000 vol $6.60 each |
7,000 | |
Filed 2019-05-06 12:40 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,500
+10,000 vol $8.45 each |
120,000 | |
Filed 2019-05-03 20:07 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$422,499
+50,000 vol $8.45 each |
50,000 | |
Filed 2019-05-03 20:02 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-03 20:00 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
Filed 2019-05-03 19:46 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,519,999
+1,600,000 vol $8.45 each |
1,600,000 | |
Filed 2019-05-03 19:39 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-03 19:36 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-02 15:59 Tx date 2018-12-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,499 vol |
435,200 | |
Filed 2019-05-02 15:58 Tx date 2018-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$7,498
+3,499 vol $2.14 each |
||
Filed 2019-05-02 15:54 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-45,178 vol |
340,224 | |
Filed 2019-05-02 15:50 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$192,006
+45,178 vol $4.25 each |
542,617 | |
Filed 2018-12-13 19:37 Tx date 2018-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$7,498
+3,499 vol $2.14 each |
||
Filed 2019-04-26 18:49 Tx date 2019-04-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-293,285.452
-34,733 vol $8.44 each |
253,266 | |
Filed 2019-04-26 18:48 Tx date 2019-04-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-85,279
-10,000 vol $8.53 each |
287,999 | |
Filed 2019-04-26 18:45 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$190,115
+44,733 vol $4.25 each |
297,999 | |
Filed 2019-04-26 18:42 Tx date 2019-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-190,115.25
-44,733 vol $4.25 each |
437,006 | |
Filed 2019-04-11 12:39 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-11 12:38 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,621,271 vol |
1,621,271 | |
Filed 2019-04-11 12:37 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-11 12:17 Tx date 2018-02-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$468,674
+145,533 vol $3.22 each |
10,513,189 | |
Filed 2019-04-11 12:16 Tx date 2018-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$1,483,050
+593,220 vol $2.50 each |
11,106,409 | |
Filed 2019-04-11 12:15 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-1,621,271 vol |
10,367,656 | |
Filed 2019-04-11 12:14 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-811,111 vol |
11,988,927 | |
Filed 2019-04-11 12:13 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,800,038 | ||
Filed 2019-04-11 12:12 Tx date 2019-02-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
-145,533 vol |
666,666 | |
Filed 2019-04-11 12:11 Tx date 2018-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
-593,220 vol |
812,199 | |
Filed 2019-04-11 12:06 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,405,419 | ||
Filed 2019-04-05 19:32 Tx date 2019-04-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-90,864
-10,000 vol $9.09 each |
297,999 | |
Filed 2019-04-03 12:16 Tx date 2019-04-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-301,500
-45,000 vol $6.70 each |
5,000 | |
Filed 2019-04-03 12:15 Tx date 2019-04-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$164,700
+45,000 vol $3.66 each |
50,000 | |
Filed 2019-04-03 12:13 Tx date 2019-04-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-164,700
-45,000 vol $3.66 each |
403,601 | |
Filed 2019-03-04 Tx date 2019-03-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-436,475
-102,700 vol $4.25 each |
481,739 | |
Filed 2019-03-04 Tx date 2019-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-449,952
-48,000 vol $9.37 each |
334,099 | |
Filed 2019-03-04 Tx date 2019-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-440,578
-47,000 vol $9.37 each |
||
Filed 2019-03-04 Tx date 2019-03-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-609,280
-68,000 vol $8.96 each |
231,399 | |
Filed 2019-03-04 Tx date 2019-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-311,977.29
-34,700 vol $8.99 each |
299,399 | |
Filed 2019-03-04 Tx date 2019-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-227,826.90
-26,100 vol $8.73 each |
307,999 | |
Filed 2019-03-04 Tx date 2019-03-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$436,475
+102,700 vol $4.25 each |
334,099 | |
Filed 2019-03-03 Tx date 2019-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-440,578
-47,000 vol $9.37 each |
335,099 | |
Filed 2019-02-20 Tx date 2019-02-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$32,599
+5,000 vol $6.52 each |
355,000 | |
Filed 2019-02-20 Tx date 2019-02-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$33,680
+8,000 vol $4.21 each |
358,000 | |
Filed 2019-02-20 Tx date 2019-02-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-33,680
-8,000 vol $4.21 each |
350,000 | |
Filed 2019-02-20 Tx date 2019-02-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-32,600
-5,000 vol $6.52 each |
350,000 | |
Filed 2019-02-11 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
110,000 | |
Filed 2019-02-08 Tx date 2019-02-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,175
-10,000 vol $8.72 each |
382,099 | |
Filed 2019-02-02 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
584,439 | |
Filed 2019-02-02 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+87,500 vol $8.04 each |
295,695 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
130,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
592,537 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
120,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
110,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
120,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
448,601 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
80,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+87,500 vol $8.04 each |
517,500 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
665,776 | |
Filed 2019-02-01 Tx date 2019-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,799
+70,000 vol $8.04 each |
497,439 | |
Filed 2019-01-31 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,600
-2,000 vol $8.30 each |
392,099 | |
Filed 2019-01-31 Tx date 2019-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,584
-8,000 vol $8.07 each |
394,099 | |
Filed 2019-01-29 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,110
+3,100 vol $8.10 each |
113,789 | |
Filed 2019-01-29 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,970
+3,700 vol $8.10 each |
1,021,206 | |
Filed 2019-01-29 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,720
+1,200 vol $8.10 each |
110,689 | |
Filed 2019-01-13 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-33,680
-8,000 vol $4.21 each |
350,000 | |
Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-65,200
-10,000 vol $6.52 each |
350,000 | |
Filed 2019-01-13 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$33,680
+8,000 vol $4.21 each |
358,000 | |
Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,199
+10,000 vol $6.52 each |
360,000 | |
Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-50,000
-12,500 vol $4.00 each |
350,000 | |
Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$50,000
+12,500 vol $4.00 each |
362,500 | |
Filed 2019-01-11 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$73,950
+17,400 vol $4.25 each |
406,301 | |
Filed 2019-01-11 Tx date 2019-01-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,720
-2,000 vol $9.86 each |
388,901 | |
Filed 2019-01-11 Tx date 2019-01-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,500
+2,000 vol $4.25 each |
390,901 | |
Filed 2019-01-11 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-72,200
-7,600 vol $9.50 each |
388,901 | |
Filed 2019-01-11 Tx date 2019-01-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-379,200
-40,000 vol $9.48 each |
396,501 | |
Filed 2019-01-11 Tx date 2019-01-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$170,000
+40,000 vol $4.25 each |
436,501 | |
Filed 2019-01-11 Tx date 2019-01-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,177.14
-17,198 vol $9.43 each |
396,501 | |
Filed 2019-01-11 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-164,952
-17,400 vol $9.48 each |
388,901 | |
Filed 2019-01-07 Tx date 2019-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-233,000
-25,000 vol $9.32 each |
413,699 | |
Filed 2019-01-03 Tx date 2018-12-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,456.40
-220 vol $6.62 each |
9,180 | |
Filed 2018-12-27 Tx date 2018-12-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,219.90
-3,500 vol $7.49 each |
402,099 | |
Filed 2018-12-20 Tx date 2018-12-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-171,477 vol |
3,500 | |
Filed 2018-12-20 Tx date 2018-12-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-3,500 vol |
0 | |
Filed 2018-12-20 Tx date 2018-12-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$7,490
+3,500 vol $2.14 each |
405,599 | |
Filed 2018-12-18 Tx date 2018-12-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,650
+1,000 vol $7.65 each |
21,452 | |
Filed 2018-12-14 Tx date 2013-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,500 | ||
Filed 2018-12-14 Tx date 2018-12-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-7,499.80
-3,500 vol $2.14 each |
0 | |
Filed 2018-12-14 Tx date 2018-12-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$7,499
+3,500 vol $2.14 each |
109,489 | |
Filed 2018-12-13 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$42,500
+10,000 vol $4.25 each |
29,252 | |
Filed 2018-12-13 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-10,000 vol |
595,776 | |
Filed 2018-12-13 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,600
-2,000 vol $6.30 each |
27,252 | |
Filed 2018-12-13 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-57,460
-6,800 vol $8.45 each |
20,452 | |
Filed 2018-12-13 Tx date 2018-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-7,498.357
-3,499 vol $2.14 each |
1 | |
Filed 2018-12-13 Tx date 2018-12-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$7,498
+3,499 vol $2.14 each |
3,500 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,189
+9,583 vol $6.28 each |
||
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,344
+9,583 vol $4.21 each |
11,066 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-48,611 vol |
225,889 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,038
+8,111 vol $3.95 each |
9,594 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$316,943
+48,611 vol $6.52 each |
50,094 | |
Filed 2018-12-10 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-124,200
-20,000 vol $6.21 each |
5,000 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,944.3799
-8,111 vol $6.28 each |
1,483 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-9,583 vol |
208,195 | |
Filed 2018-12-10 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-73,200
-20,000 vol $3.66 each |
378,601 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-8,111 vol |
217,778 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-305,320.8299
-48,611 vol $6.28 each |
1,483 | |
Filed 2018-12-10 Tx date 2018-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,189.8647
-9,583 vol $6.28 each |
1,483 | |
Filed 2018-12-10 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-73,200
-20,000 vol $3.66 each |
||
Filed 2018-12-10 Tx date 2018-12-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$73,200
+20,000 vol $3.66 each |
25,000 | |
Filed 2018-11-17 Tx date 2018-11-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-154,982.64
-22,200 vol $6.98 each |
402,099 | |
Filed 2018-11-17 Tx date 2018-11-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-100,805.76
-14,400 vol $7.00 each |
424,299 | |
Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,402
-600 vol $5.67 each |
0 | |
Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,695
-4,500 vol $5.71 each |
0 | |
Filed 2018-10-15 Tx date 2018-10-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,690
-1,000 vol $5.69 each |
0 | |
Filed 2018-06-20 Tx date 2018-06-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,172
+700 vol $5.96 each |
4,500 | |
Filed 2018-06-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
-1,483 vol |
0 | |
Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,660
+3,800 vol $5.70 each |
3,800 | |
Filed 2018-06-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600 | ||
Filed 2018-06-12 Tx date 2018-06-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,107
+1,483 vol $2.77 each |
1,483 | |
Filed 2018-06-07 Tx date 2018-05-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,483 vol |
0 | |
Filed 2018-06-07 Tx date 2018-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,483 vol |
0 | |
Filed 2018-06-07 Tx date 2018-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$4,107
+1,483 vol $2.77 each |
56,055 | |
Filed 2018-06-07 Tx date 2018-05-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$4,107
+1,483 vol $2.77 each |
19,252 | |
Filed 2018-05-30 Tx date 2018-05-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$205,403
+74,153 vol $2.77 each |
||
Filed 2018-05-30 Tx date 2018-05-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-205,401.04
-74,152 vol $2.77 each |
0 | |
Filed 2018-05-30 Tx date 2018-05-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-222,222.50
-88,889 vol $2.50 each |
74,152 | |
Filed 2018-05-30 Tx date 2018-05-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$205,403
+74,153 vol $2.77 each |
1,017,506 | |
Filed 2018-05-30 Tx date 2018-05-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$222,222
+88,889 vol $2.50 each |
105,989 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$135,600
+40,000 vol $3.39 each |
65,000 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-22,500 vol |
274,500 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-23,000 vol |
297,000 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-40,000 vol |
320,000 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-129,750
-25,000 vol $5.19 each |
360,000 | |
Filed 2018-05-21 Tx date 2018-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-56,525.40
-9,300 vol $6.08 each |
0 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-616,308
-101,200 vol $6.09 each |
9,300 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$94,725
+22,500 vol $4.21 each |
110,500 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$129,750
+25,000 vol $5.19 each |
25,000 | |
Filed 2018-05-21 Tx date 2018-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,850
-4,500 vol $5.30 each |
0 | |
Filed 2018-05-21 Tx date 2018-03-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,290
-1,000 vol $5.29 each |
0 | |
Filed 2018-05-21 Tx date 2018-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$90,850
+23,000 vol $3.95 each |
88,000 | |
Filed 2018-03-28 Tx date 2018-03-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-28 Tx date 2018-03-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,059,000
+150,000 vol $7.06 each |
150,000 | |
Filed 2018-03-28 Tx date 2018-03-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,059,000
+150,000 vol $7.06 each |
||
Filed 2018-03-02 Tx date 2018-02-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2018-02-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,000
+50,000 vol $6.92 each |
50,000 | |
Filed 2018-02-14 Tx date 2018-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$320,000
+50,000 vol $6.40 each |
50,000 | |
Filed 2018-02-14 Tx date 2018-02-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-13 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,467,000
+225,000 vol $6.52 each |
522,537 | |
Filed 2018-02-09 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
90,000 | |
Filed 2018-02-09 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
80,000 | |
Filed 2018-02-09 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
90,000 | |
Filed 2018-02-07 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
80,000 | |
Filed 2018-02-07 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$977,999
+150,000 vol $6.52 each |
398,601 | |
Filed 2018-02-07 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,141,000
+175,000 vol $6.52 each |
385,000 | |
Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,304,000
+200,000 vol $6.52 each |
350,000 | |
Filed 2018-02-06 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
100,000 | |
Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Mandt, Lawrence Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$488,999
+75,000 vol $6.52 each |
140,877 | |
Filed 2018-02-06 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,568,000
+400,000 vol $6.42 each |
1,670,000 | |
Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$977,999
+150,000 vol $6.52 each |
430,000 | |
Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$977,999
+150,000 vol $6.52 each |
605,776 | |
Filed 2018-02-04 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,141,000
+175,000 vol $6.52 each |
514,439 | |
Filed 2018-02-03 Tx date 2018-01-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+500 vol $5.52 each |
500 | |
Filed 2018-02-03 Tx date 2018-01-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+500 vol $5.28 each |
1,000 | |
Filed 2018-02-03 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$977,999
+150,000 vol $6.52 each |
427,439 | |
Filed 2017-12-15 Tx date 2017-12-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,172
+250 vol $4.69 each |
9,400 | |
Filed 2017-12-04 Tx date 2017-11-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,456
+3,800 vol $5.12 each |
3,800 | |
Filed 2017-12-04 Tx date 2017-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-29 Tx date 2017-11-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,351
+263 vol $5.14 each |
4,500 | |
Filed 2017-11-17 Tx date 2017-11-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,857
+3,900 vol $6.63 each |
943,353 | |
Filed 2017-10-25 Tx date 2017-10-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,952
+1,750 vol $5.69 each |
9,150 | |
Filed 2017-10-24 Tx date 2017-10-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,100
+5,000 vol $5.82 each |
5,000 | |
Filed 2017-07-21 Tx date 2017-07-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,160
-2,000 vol $7.08 each |
4,237 | |
Filed 2017-07-19 Tx date 2017-04-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-733,735.604
-106,904 vol $6.86 each |
2,770,909 | |
Filed 2017-07-19 Tx date 2017-04-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-169,251.1184
-24,092 vol $7.03 each |
2,877,813 | |
Filed 2017-07-19 Tx date 2017-04-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,217,351.6627
-445,487 vol $7.22 each |
2,901,905 | |
Filed 2017-07-19 Tx date 2017-04-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,265,365.90
-193,000 vol $6.56 each |
3,347,392 | |
Filed 2017-07-19 Tx date 2017-04-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,805,083.4958
-260,903 vol $6.92 each |
3,540,392 | |
Filed 2017-07-19 Tx date 2017-04-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-656,672.87
-94,225 vol $6.97 each |
3,801,295 | |
Filed 2017-07-19 Tx date 2017-04-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,227,495
-173,375 vol $7.08 each |
3,895,520 | |
Filed 2017-07-19 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,934,089.41
-540,026 vol $7.29 each |
4,068,895 | |
Filed 2017-07-19 Tx date 2017-05-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
-615,575 vol |
0 | |
Filed 2017-07-19 Tx date 2017-05-10 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
$-826,185.93
-115,188 vol $7.17 each |
615,575 | |
Filed 2017-07-19 Tx date 2017-05-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
$-995,809.5392
-140,168 vol $7.10 each |
730,763 | |
Filed 2017-07-19 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
$-1,284,574.748
-181,240 vol $7.09 each |
870,931 | |
Filed 2017-07-19 Tx date 2017-05-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
$-1,526,264.2116
-215,702 vol $7.08 each |
1,052,171 | |
Filed 2017-07-19 Tx date 2017-05-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
59 - Exercise for cash
|
$-686,164.77
-96,507 vol $7.11 each |
1,267,873 | |
Filed 2017-07-19 Tx date 2017-04-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,267,810.5881
-2,069,959 vol $7.38 each |
0 | |
Filed 2017-07-19 Tx date 2017-04-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,300,889.897
-186,430 vol $6.98 each |
2,069,959 | |
Filed 2017-07-19 Tx date 2017-04-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,874,735.98
-273,800 vol $6.85 each |
2,256,389 | |
Filed 2017-07-19 Tx date 2017-04-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,196,913.056
-176,320 vol $6.79 each |
2,530,189 | |
Filed 2017-07-19 Tx date 2017-04-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-437,437
-64,400 vol $6.79 each |
2,706,509 | |
Filed 2017-07-19 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,735,232.719
-246,587 vol $7.04 each |
4,608,921 | |
Filed 2017-07-19 Tx date 2017-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,735,232.719
-246,587 vol $7.04 each |
||
Filed 2017-07-19 Tx date 2017-03-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,460,923.74
-602,014 vol $7.41 each |
4,855,508 | |
Filed 2017-07-14 Tx date 2017-07-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,268,000
+280,000 vol $8.10 each |
280,000 | |
Filed 2017-07-14 Tx date 2017-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-07 Tx date 2017-07-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-20,539.55
-7,415 vol $2.77 each |
0 | |
Filed 2017-07-07 Tx date 2017-07-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-46,492.05
-7,415 vol $6.27 each |
0 | |
Filed 2017-07-07 Tx date 2017-07-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$20,539
+7,415 vol $2.77 each |
7,415 | |
Filed 2017-07-06 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,400 | ||
Filed 2017-07-04 Tx date 2017-06-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,800
-4,000 vol $6.20 each |
23,769 | |
Filed 2017-07-04 Tx date 2017-06-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,420
-6,000 vol $8.07 each |
17,769 | |
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-136,649.70
-21,186 vol $6.45 each |
0 | |
Filed 2017-06-30 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-16,399 vol |
248,601 | |
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-16,399 vol |
||
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-105,773.55
-16,399 vol $6.45 each |
0 | |
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,020
+16,399 vol $3.66 each |
16,399 | |
Filed 2017-06-30 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$59,200
+16,399 vol $3.61 each |
||
Filed 2017-06-28 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-28 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2017-06-27 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$70,000
+20,000 vol $3.50 each |
37,769 | |
Filed 2017-06-27 Tx date 2017-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,400
-5,000 vol $8.68 each |
32,769 | |
Filed 2017-06-27 Tx date 2017-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,650
-3,000 vol $6.55 each |
29,769 | |
Filed 2017-06-27 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-69,040
-8,000 vol $8.63 each |
21,769 | |
Filed 2017-06-27 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,240
-4,000 vol $6.56 each |
17,769 | |
Filed 2017-06-27 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,540
-6,000 vol $6.59 each |
31,769 | |
Filed 2017-06-27 Tx date 2017-06-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,160
-4,000 vol $8.79 each |
27,769 | |
Filed 2017-06-27 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-20,000 vol |
455,776 | |
Filed 2017-06-23 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-117,647.64
-13,200 vol $8.91 each |
625,499 | |
Filed 2017-06-23 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-315,645.8844
-36,762 vol $8.59 each |
438,699 | |
Filed 2017-06-23 Tx date 2017-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-283,012.605
-32,850 vol $8.62 each |
475,461 | |
Filed 2017-06-23 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,015,363.7072
-117,188 vol $8.66 each |
508,311 | |
Filed 2017-06-23 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-117,647.64
-13,200 vol $8.91 each |
625,499 | |
Filed 2017-06-23 Tx date 2013-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,296,258 vol |
638,699 | |
Filed 2017-06-23 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-315,645.8844
-36,762 vol $8.59 each |
438,699 | |
Filed 2017-06-23 Tx date 2017-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-283,012.605
-32,850 vol $8.62 each |
475,461 | |
Filed 2017-06-23 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,015,363.7072
-117,188 vol $8.66 each |
508,311 | |
Filed 2017-05-03 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,499
+50,000 vol $9.45 each |
210,000 | |
Filed 2017-05-01 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Ayers, Gregory Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
50,000 | |
Filed 2017-04-28 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
60,000 | |
Filed 2017-04-28 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
70,000 | |
Filed 2017-04-28 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
50,000 | |
Filed 2017-04-28 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
60,000 | |
Filed 2017-03-22 Tx date 2017-03-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
-145,533 vol |
0 | |
Filed 2017-03-22 Tx date 2017-03-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+145,533 vol |
1,405,419 | |
Filed 2017-03-22 Tx date 2017-03-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$34,999,998
+5,185,185 vol $6.75 each |
12,800,039 | |
Filed 2017-03-22 Tx date 2017-03-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,586,606 vol |
7,614,854 | |
Filed 2017-03-22 Tx date 2017-03-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-4,586,606 vol |
0 | |
Filed 2017-03-02 Tx date 2017-02-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,300
+10,000 vol $4.73 each |
40,000 | |
Filed 2017-03-02 Tx date 2017-02-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,300
+10,000 vol $4.73 each |
40,000 | |
Filed 2017-02-21 Tx date 2017-02-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,300
+10,000 vol $4.73 each |
50,000 | |
Filed 2017-02-19 Tx date 2017-02-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,300
+10,000 vol $4.73 each |
30,000 | |
Filed 2017-02-15 Tx date 2017-02-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-3.75
-15 vol $0.25 each |
160,000 | |
Filed 2017-02-15 Tx date 2017-02-13 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-2.00
-10 vol $0.20 each |
160,015 | |
Filed 2017-02-15 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+65,000 vol |
265,000 | |
Filed 2017-02-15 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+65,000 vol |
||
Filed 2017-02-14 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$639,920
+152,000 vol $4.21 each |
339,439 | |
Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$378,900
+90,000 vol $4.21 each |
277,439 | |
Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$463,100
+110,000 vol $4.21 each |
297,537 | |
Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$736,750
+175,000 vol $4.21 each |
475,776 | |
Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,420,500
+1,050,000 vol $4.21 each |
1,270,000 | |
Filed 2017-02-13 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+65,000 vol |
265,000 | |
Filed 2017-02-10 Tx date 2017-02-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+55,000 vol |
160,025 | |
Filed 2017-01-27 Tx date 2017-01-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,835
-3,000 vol $2.94 each |
6,237 | |
Filed 2017-01-27 Tx date 2017-01-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5.00
-25 vol $0.20 each |
105,025 | |
Filed 2017-01-25 Tx date 2017-01-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
20,000 | |
Filed 2017-01-12 Tx date 2016-12-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,499,998
+666,666 vol $2.25 each |
1,259,886 | |
Filed 2017-01-12 Tx date 2016-12-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,999,999
+1,333,333 vol $2.25 each |
3,028,248 | |
Filed 2017-01-12 Tx date 2017-01-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$5.00
+50 vol $0.10 each |
105,050 | |
Filed 2017-01-06 Tx date 2017-01-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,186
+770 vol $2.84 each |
770 | |
Filed 2017-01-06 Tx date 2014-06-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-05 Tx date 2017-01-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$932.45
+434 vol $2.15 each |
334,865 | |
Filed 2017-01-05 Tx date 2017-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$141,186
+65,714 vol $2.15 each |
334,431 | |
Filed 2017-01-05 Tx date 2017-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,213
+33,852 vol $2.13 each |
268,717 | |
Filed 2017-01-03 Tx date 2016-12-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
Filed 2017-01-03 Tx date 2016-11-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-01-03 Tx date 2017-01-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,180
+2,000 vol $2.09 each |
9,237 | |
Filed 2016-10-07 Tx date 2016-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
-333,333 vol |
145,533 | |
Filed 2016-10-07 Tx date 2016-09-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$833,332
+333,333 vol $2.50 each |
4,586,606 | |
Filed 2016-09-26 Tx date 2016-09-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,000 vol |
187,537 | |
Filed 2016-09-01 Tx date 2016-08-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
188,537 | |
Filed 2016-09-01 Tx date 2016-08-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
300,776 | |
Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
||
Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
||
Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
||
Filed 2016-08-11 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
||
Filed 2016-08-09 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,000 vol |
188,537 | |
Filed 2016-08-09 Tx date 2016-08-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
300,776 | |
Filed 2016-07-28 Tx date 2016-07-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,545
-1,500 vol $3.03 each |
0 | |
Filed 2016-07-28 Tx date 2016-07-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
105,000 | |
Filed 2016-06-28 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$1,399,999
+593,220 vol $2.36 each |
593,220 | |
Filed 2016-06-28 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$205,401
+74,152 vol $2.77 each |
163,041 | |
Filed 2016-06-28 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,999,999
+1,694,915 vol $2.36 each |
1,694,915 | |
Filed 2016-06-28 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-28 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-27 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,001
+211,865 vol $2.36 each |
939,453 | |
Filed 2016-06-24 Tx date 2016-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-24 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+7,415 vol |
7,415 | |
Filed 2016-06-24 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,001
+211,865 vol $2.36 each |
234,865 | |
Filed 2016-06-24 Tx date 2014-07-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-24 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+74,153 vol |
74,153 | |
Filed 2016-06-24 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$49,998
+21,186 vol $2.36 each |
21,186 | |
Filed 2016-06-24 Tx date 2016-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+4,237 vol $2.36 each |
37,769 | |
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+4,237 vol $2.36 each |
7,237 | |
Filed 2016-06-23 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,483 vol |
1,483 | |
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+4,237 vol $2.36 each |
54,572 | |
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,483 vol |
1,483 | |
Filed 2016-06-23 Tx date 2016-06-22 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,483 vol |
1,483 | |
Filed 2016-06-18 Tx date 2016-06-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,200,000
+1,000,000 vol $3.20 each |
1,040,000 | |
Filed 2016-05-05 Tx date 2016-05-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
200,000 | |
Filed 2016-05-05 Tx date 2016-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-04-01 Tx date 2016-03-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Zaruby, Stephen Walter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,400
+40,000 vol $3.76 each |
1,230,717 | |
Filed 2016-04-01 Tx date 2016-03-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$156,400
+40,000 vol $3.91 each |
192,537 | |
Filed 2016-04-01 Tx date 2016-03-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$156,400
+40,000 vol $3.91 each |
310,776 | |
Filed 2016-03-31 Tx date 2016-03-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$156,400
+40,000 vol $3.91 each |
187,439 | |
Filed 2016-03-31 Tx date 2016-03-30 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$156,400
+40,000 vol $3.91 each |
187,439 | |
Filed 2016-03-28 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,500
-1,500 vol $3.00 each |
1,500 | |
Filed 2016-03-28 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2016-03-28 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2016-03-27 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Ayers, Gregory Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2016-03-25 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
220,000 | |
Filed 2016-03-24 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rowland, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
40,000 | |
Filed 2016-03-24 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
40,000 | |
Filed 2016-01-21 Tx date 2016-01-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,686
+1,000 vol $1.69 each |
3,000 | |
Filed 2016-01-21 Tx date 2016-01-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+1,000 vol $2.90 each |
3,000 | |
Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
Filed 2016-01-12 Tx date 2016-01-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 |